Hideki Tsutsumi Selected Research

Soot

1/2012

Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideki Tsutsumi Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 01/2011
2	Body Weight (Weight, Body) 01/2018 - 01/2005
1	Hypertrophy 01/2018
1	Teratoma (Teratoid Tumor) 01/2018
1	Papilloma (Papillomatosis) 01/2011
1	Carcinogenesis 01/2011
1	Hypoxia (Hypoxemia) 01/2011
1	Ischemia 01/2011
1	Osteoporosis 01/2005

Drug/Important Bio-Agent (IBA)

1	anthraceneIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2018
1	NitrogenIBA 01/2018
1	Valsartan (Vals)FDA Link 01/2018
1	SootIBA 01/2012
1	Hypoxia-Inducible Factor 1IBA 01/2011
1	Transcription Factors (Transcription Factor)IBA 01/2011
1	Oxygen (Dioxygen)IBA 01/2011
1	CarcinogensIBA 01/2011
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2011
1	GlucocorticoidsIBA 01/2005
1	alfacalcidolIBA 01/2005
1	Prednisolone (Predate)FDA LinkGeneric 01/2005
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2005

Therapy/Procedure

2	Transplantation 01/2018 - 06/2015